Literature DB >> 15703813

Additional Cyclin D(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma.

Jochen Utikal1, Martin Udart, Ulrike Leiter, Ralf Uwe Peter, Gertraud Krähn.   

Abstract

Cyclin D1 (CCND1, PRAD1, bcl-1) is associated with progression through G1 and entry into S phase of the cell cycle, as a partner of cyclin-dependent kinases (CDKs). The aim of this study was to evaluate cytogenetic aberrations of the gene locus at chromosome 11q13 in cutaneous malignant melanoma. Fluorescence in situ hybridisation (FISH) was applied on metaphase spreads of short-term primary cell cultures as well as on 5 microm paraffin tissue sections of primary melanomas and melanoma metastases, and on melanoma cell lines (C32, WM 266-4, HT 144, RPMI 7951, SK MEL 28). For FISH analysis DNA probes specific for Cyclin D1, centromere 11 and painting probes for whole chromosome 11 were used. FISH revealed additional Cyclin D1 gene copies in relation to centromere 11 copy numbers in 9/19 (47%) primary melanomas and in 7/20 (35%) melanoma metastases. The melanoma cell line SK MEL 28 also showed extra Cyclin D1 gene copies. A 24-colour FISH (mFISH) investigation revealed translocated chromosome 11 material to chromosomes 12, 14, 15, 20, 21, 22 and Y in these cases, respectively. Positivity for Cyclin D1 protein was detected by immunostaining in 17/19 (89%) primary melanomas (10 weak, 7 strong expression) and in 9/12 (75%) melanoma metastases (5 weak and 4 strong). All primary melanomas and 3/4 examined metastases with additional Cyclin D1 gene copies concomitantly revealed positive protein staining. Based on these results Cyclin D1 could well be involved in the pathogenesis of a subset of malignant melanoma. Additional studies will have to elucidate the role of further genes located at chromosome 11q13.

Entities:  

Mesh:

Year:  2005        PMID: 15703813

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

Review 1.  Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?

Authors:  József Tímár; Balázs Gyorffy; Erzsébet Rásó
Journal:  Clin Exp Metastasis       Date:  2010-02-24       Impact factor: 5.150

2.  Identification of MET and SRC activation in melanoma cell lines showing primary resistance to PLX4032.

Authors:  Elisabetta Vergani; Viviana Vallacchi; Simona Frigerio; Paola Deho; Piera Mondellini; Paola Perego; Giuliana Cassinelli; Cinzia Lanzi; Maria Adele Testi; Licia Rivoltini; Italia Bongarzone; Monica Rodolfo
Journal:  Neoplasia       Date:  2011-12       Impact factor: 5.715

3.  Perivascular epithelioid cell neoplasms (PEComas): four malignant cases expanding the histopathological spectrum and a description of a unique finding.

Authors:  Ilan Weinreb; David Howarth; Eleanor Latta; Danny Ghazarian; Runjan Chetty
Journal:  Virchows Arch       Date:  2007-02-15       Impact factor: 4.064

4.  Rewired ERK-JNK signaling pathways in melanoma.

Authors:  Pablo Lopez-Bergami; Conway Huang; James S Goydos; Dana Yip; Menashe Bar-Eli; Meenhard Herlyn; Keiran S M Smalley; Alka Mahale; Alexey Eroshkin; Stuart Aaronson; Ze'ev Ronai
Journal:  Cancer Cell       Date:  2007-05       Impact factor: 31.743

Review 5.  NF-kappaB activation in melanoma.

Authors:  Yukiko Ueda; Ann Richmond
Journal:  Pigment Cell Res       Date:  2006-04

6.  Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells.

Authors:  Elena Daveri; Giuseppe Valacchi; Roberta Romagnoli; Emilia Maellaro; Emanuela Maioli
Journal:  Evid Based Complement Alternat Med       Date:  2015-05-28       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.